Home
>
National Drug Code (NDC)
>
Adenosine
Adenosine - 10019-063-03 - (ADENOSINE)
Drug Information of Adenosine
| Product NDC: | 10019-063 |
| Proprietary Name: | Adenosine |
| Non Proprietary Name: | ADENOSINE |
| Active Ingredient(s): | 3 mg/mL & nbsp; ADENOSINE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Adenosine
| Product NDC: | 10019-063 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076500 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100420 |
Package Information of Adenosine
| Package NDC: | 10019-063-03 |
| Package Description: | 10 VIAL in 1 PACKAGE (10019-063-03) > 2 mL in 1 VIAL (10019-063-02) |
NDC Information of Adenosine
| NDC Code | 10019-063-03 |
| Proprietary Name | Adenosine |
| Package Description | 10 VIAL in 1 PACKAGE (10019-063-03) > 2 mL in 1 VIAL (10019-063-02) |
| Product NDC | 10019-063 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ADENOSINE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20100420 |
| Marketing Category Name | ANDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | ADENOSINE |
| Strength Number | 3 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA] |
